Specialty Ingredients and Excipients for Biologics: Impact of COVID-19 on the Global Market

Base Year: 2019
Published June 2020
Regional Coverage: Global

A special report on the impact of COVID-19 on the global market of specialty chemicals in biologic pharmaceuticals, with forecasts for different scenarios that the industry is likely to face.

Scope

  • A comprehensive analysis of global biopharmaceuticals industry developments and their impact on demand for specialty chemicals in different stages of production, including:
    • Upstream Manufacturing
      • Classic cell culture media, Cell Expression Systems, Cell Culture Ingredients and Supplements, and Buffers
    • — Downstream Processing
      • Stabilizers, Surfactants, Salts, Antioxidants, and Buffers
    • — Final Formulation
      • Stabilizers and Bulking Agents, Surfactants, Salts, Antioxidants, Buffers, Vaccine Adjuvants, and Chelating Agents
  • This report analyzes four key scenarios of development:
    • CASE 1: mAbs as a cure
    • — CASE 2: Vaccine developed
    • — CASE 3: Success in Recombinant Technology
    • — CASE 4: Small-Molecule Drugs as Winners

Table of Contents

Introduction 

  • Scope
  • Sources
  • Assumption
  • Research Methodology

COVID-19’s Impact on the Biopharmaceutical Industry

  • Impact of COVID-19
  • Developments in the Drug Pipeline
  • Estimated Consumption
  • Existing and Future Drug Options

Global Outlook

  • Outlook of Biopharmaceuticals
  • Potential Growth Scenarios
  • Biologics Ingredients and Excipients Forecast

Report Benefits

This report serves as an excellent resource for manufacturers and suppliers of pharmaceutical raw ingredients. Specifically, it assists subscribers by providing:

  • Actionable forecasts on thepotential impact of COVID-19
  • Insights into industry developments and likely scenarios
  • Insights into market behavior in different scenarios

Price Anchor

Posted in .